English
Polski
Español
українська
WHO update on drug-resistant tuberculosis
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, discusses the WHO guideline update on multidrug-resistant tuberculosis.
2017-09-04
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, discusses the WHO guideline update on multidrug-resistant tuberculosis.
Dr Gordon Guyatt, Distinguished Professor at McMaster University Department of Health Research Methods, Evidence, and Impact and one of the founders of evidence-based medicine, discusses new Canadian guidelines on opioid use in chronic noncancer pain.
Dr Holger Schünemann explains in what ways new European breast cancer screening guidelines differ from previously issued recommendations and talks about their implementation.
Dr Holger Schünemann, chair of the Department of Health, Evidence and Impact at McMaster University, on reasons and methods for developing European breast cancer screening guidelines.
In the final episode on colorectal cancer screening, Dr David Morgan discusses FIT tests and the future of screening.
Dr Paul O’Byrne, Dean and Vice-President of Faculty of Health Sciences at McMaster University, discusses fish oil supplementation in pregnancy and in patients with asthma.
In the second McMaster Perspective episode on colorectal cancer screening, Dr David Morgan compares acceptability and efficacy of different screening strategies.
Dr Gordon Guyatt discusses new AABB guidelines on blood transfusion, explaining the rationale for different thresholds and why fresh blood may not always be better.
Dr David Morgan, professor of gastroenterology at McMaster University, discusses the prevalence and screening modalities for colorectal cancer.
In the sixth, final episode of our Surviving Sepsis Campaign review series, Prof. Bram Rochwerg discusses the updated recommendations on ventilation.
